| Hans-Günter Meyer-Thompson | Amphetamine
Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD).
Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD).
Alda JA, Soutullo C, Ramos-Quiroga JA, Quintero J, Hervás A, Hernández-Otero I, Sans-Fitó A, Cardo-Jalón EC, Fernández-Jaén A, Fernández-Pérez M, Hidalgo-Vicario MI, Eddy-Ives LS, Sánchez J.
Actas Esp Psiquiatr. 2014 Dec;42 Suppl:1-16.
https://www.actaspsiquiatria.es/repositorio//suplements/16/ENG/16-ENG-176519.pdf